Skip to content
Skip to service links: contact, tools, help, the group
Skip to search
Skip to main navigation
Skip to sub navigation
Skip to Footer with links to masthead, print, email a friend and disclaimer

Cryogenic Supply Chain Solutions in Japan

Regenerative medicine using stem cells such as iPS cells is becoming a new option for clinical treatment. This market is expected to grow rapidly as regenerative medicine has substantial potential to improve human health. To support the development and industrialization of regenerative medicine, DHL has built a scheme for storage and transportation of cells at ultra-low temperature using liquid nitrogen. Leveraging our experience accumulated through clinical trial logistics, we offer high-quality logistic service to all our customers involved in regenerative medicine.